Jefferies Group acquired 21.4 Thousand Theravance Biopharma shares worth $192 Thousand. That's 0.00% of their equity portfolio (1001st largest holding). The first Theravance Biopharma trade was made in Q2 2023. Since then Jefferies Group bought shares two more times and sold shares on one occasions. The investor's estimated purchase price is $199 Thousand, resulting in a loss of 3.4%.
pupunkkop This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis....
Top healthcare stocks include Theravance Biopharma for best value, Signify Health for fastest growth, and TransMedics Group for most momentum.
Vanguard Group Inc. grew its position in shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) by 16.9% during the second quarter, according to its most recent ...
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus In...